Related Experiment Video
Updated: Oct 15, 2025
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
33.6K
Melatonin attenuates morphine-induced conditioned place preference in Wistar rats
Fahad S Alshehri1, Badrah S Alghamdi2,3, Alqassem Y Hakami4,5
1Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
Brain and Behavior
|October 28, 2021
Summary
Melatonin may help reduce morphine dependence and seeking behaviors. This study found that melatonin administration attenuated morphine-induced place preference in rats, suggesting a potential therapeutic role.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Morphine is a primary analgesic for severe pain but carries a high risk of abuse and dependence.
- Opioid dependence remains a significant challenge in pain management, necessitating the exploration of alternative therapeutic strategies.
- Melatonin, a neurohormone regulating circadian rhythms, has shown efficacy in reducing alcohol-seeking behaviors.
Purpose of the Study:
- To investigate the potential of the melatonergic system in attenuating morphine dependence.
- To evaluate the effect of melatonin on morphine-seeking behavior using a conditioned place preference (CPP) model in rats.
Main Methods:
- Male Wistar rats were assigned to control, morphine, or morphine + melatonin groups.
- Morphine dependence was induced over 8 days with daily injections.
- Melatonin's effect on morphine-seeking behavior was assessed via a CPP test post-treatment.
Main Results:
- Repeated morphine administration significantly increased CPP scores, indicating induced place preference.
- A single dose of melatonin, administered before the preference test, effectively attenuated morphine-seeking behavior.
- Melatonin reduced the place preference associated with morphine administration.
Conclusions:
- The melatonergic system plays a role in modulating morphine-seeking behavior.
- Melatonin shows promise as a potential therapeutic target for reducing opioid dependence and abuse.
- Further research into melatonin's mechanisms could lead to novel treatments for opioid use disorders.
Related Concept Videos
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
280
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
280
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
517
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
517
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
461
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
461
01:19Management of Insomnia
341
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
341
01:25Analgesia and Pain Management
941
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
941
01:22Opioid Receptors: Overview
2.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.4K